This inventor holds 1 USPTO granted patent. Top assignee: Leland Stanford Junior University. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Innovations in Regenerative Medicine by Jonathan A Mathy
Introduction
Jonathan A Mathy is an accomplished inventor based in Boston, MA (US). He has made significant contributions to the field of regenerative medicine, particularly in the areas of hair, bone, and cartilage regeneration. His innovative approaches have the potential to enhance healing and recovery in various medical applications.
Latest Patents
Jonathan A Mathy holds a patent for the "Use of Del-1 in hair, bone and cartilage regeneration." This patent describes methods and compositions that enhance bone density or formation. It includes techniques for stabilizing bone grafts, repairing bones, and joint replacements. The patent also addresses cartilage repair by providing a composition that includes Del-1 locally to a site, which enhances the survival or differentiation of chondrocytes. Additionally, the methods provided stimulate hair regrowth, showcasing the versatility of his research.
Career Highlights
Jonathan A Mathy is affiliated with Leland Stanford Junior University, where he continues to advance his research in regenerative medicine. His work has garnered attention for its innovative approaches and practical applications in medical science. With a focus on enhancing bone density and promoting hair regrowth, Mathy's contributions are paving the way for new treatment options.
Collaborations
Some of his notable coworkers include George P Yang and Thomas Quertermous. Their collaborative efforts contribute to the ongoing research and development in the field of regenerative medicine.
Conclusion
Jonathan A Mathy is a pioneering inventor whose work in regenerative medicine is making a significant impact. His innovative patent on the use of Del-1 for enhancing bone density and stimulating hair regrowth exemplifies his commitment to advancing medical science. Through his research and collaborations, Mathy is helping to shape the future of regenerative therapies.
